Table 5

Risk ratios, 95% CIs and p values for all the features from the modified Poisson regression and Bayesian network models for ventilation admissions

	Modified poisson				Bayesian network
	Ventilation risk ratio	Ventilation lower CI	Ventilation upper CI	Ventilation p value	Ventilation Risk ratio	Ventilation lower CI	Ventilation upper CI	Ventilation p value
Moderate activity versus low activity	0.73	0.62	0.84	<0.001	0.63	0.54	0.74	<0.001
High activity versus low activity	0.55	0.47	0.64	<0.001	0.39	0.33	0.46	<0.001
35–49 vs below 35	3.51	2.54	4.84	<0.001	3.48	2.64	4.58	<0.001
50–59 vs below 35	4.90	3.51	6.84	<0.001	7.10	5.37	9.39	<0.001
60+ vs below 35	5.53	3.90	7.85	<0.001	13.67	10.31	18.12	<0.001
Males versus females	2.53	2.15	2.96	<0.001	2.47	2.12	2.87	<0.001
RUB 1 vs RUB 0	2.03	0.80	5.18	0.069	2.26	0.82	6.26	0.159
RUB 2 vs RUB 0	2.46	1.04	5.81	0.020	3.11	1.21	8.00	0.019
RUB 3 vs RUB 0	4.18	1.86	9.40	<0.001	5.62	2.29	13.78	<0.001
RUB 4 vs RUB 0	26.83	11.92	60.37	<0.001	38.33	15.66	93.77	<0.001
RUB 5 vs RUB 0	87.82	38.98	197.84	<0.001	131.74	53.91	321.95	<0.001
Oncology	2.31	1.70	3.15	<0.001	0.93	0.58	1.48	0.758
Hypercholesterolaemia	0.76	0.64	0.90	<0.001
Angina syndrome	0.77	0.11	5.20	0.398
Congestive cardiac failure	0.78	0.48	1.28	0.156
Cardiomyopathy	0.79	0.32	1.95	0.320
Essential hypertension	1.44	1.24	1.67	<0.001	1.31	1.09	1.57	0.003
Diabetes mellitus	1.26	1.04	1.53	0.008	1.48	1.14	1.93	0.003
Hypothyroidism	0.90	0.64	1.27	0.282
Crohns disease	0.66	0.20	2.16	0.241
Ulcerative colitis	0.43	0.14	1.31	0.065
HIV	0.76	0.46	1.25	0.139	1.26	0.78	2.04	0.343
Systemic lupus erythematosus	0.73	0.26	2.05	0.281
Rheumatoid arthritis	1.40	1.01	2.01	0.033	2.60	1.67	4.04	<0.001
Chronic renal failure	0.64	0.36	1.14	0.053	4.25	2.19	8.25	<0.001
Epilepsy	0.85	0.53	1.37	0.211
Asthma	1.03	0.84	1.27	0.422
Conduction disorder	0.61	0.40	0.95	0.013
Multiple sclerosis	0.70	0.19	2.59	0.298
Bronchiectasis	0.66	0.12	3.54	0.324

RUB, resource utilisation band.